Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 1/2012

01-02-2012 | Hospital Management of Diabetes (M Korytkowski, Section Editor)

Medical Nutrition Therapy in Hospitalized Patients with Diabetes

Authors: Aidar R. Gosmanov, Guillermo E. Umpierrez

Published in: Current Diabetes Reports | Issue 1/2012

Login to get access

Abstract

Medical nutrition therapy (MNT) plays an important role in management of hyperglycemia in hospitalized patients with diabetes mellitus. The goals of inpatient MNT are to optimize glycemic control, to provide adequate calories to meet metabolic demands, and to create a discharge plan for follow-up care. All patients with and without diabetes should undergo nutrition assessment on admission with subsequent implementation of physiologically sound caloric support. The use of a consistent carbohydrate diabetes meal-planning system has been shown to be effective in facilitating glycemic control in hospitalized patients with diabetes. This system is based on the total amount of carbohydrate offered rather than on specific calorie content at each meal, which facilitates matching the prandial insulin dose to the amount of carbohydrate consumed. In this article, we discuss general guidelines for the implementation of appropriate MNT in hospitalized patients with diabetes.
Literature
1.
Correia MI, Waitzberg DL. The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clinical nutrition (Edinburgh, Scotland). 2003;22:235–9.CrossRef
2.
• Ziegler TR 2009. Parenteral nutrition in the critically ill patient. The New England journal of medicine 361: 1088–1097. This is a state-of-the-art review article describing current evidence for the use of PN in the hospitalized patients
3.
Daley J, Khuri SF, Henderson W, et al. Risk adjustment of the postoperative morbidity rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg. 1997;185:328–40.PubMed
4.
Warnold I, Lundholm K. Clinical significance of preoperative nutritional status in 215 noncancer patients. Ann Surg. 1984;199:299–305.PubMedCrossRef
5.
Giner M, Laviano A, Meguid MM, et al. In 1995 a correlation between malnutrition and poor outcome in critically ill patients still exists. Nutrition (Burbank, Los Angeles County Calif. 1996;12:23–9.CrossRef
6.
Marik PE. Monitoring therapeutic interventions in critically ill septic patients. Nutr Clin Pract. 2004;19:423–32.PubMedCrossRef
7.
Martindale RG, Cresci G. Preventing infectious complications with nutrition intervention. Jpen. 2005;29:S53–56.CrossRef
8.
Strickland SS. Functional consequences of adult malnutrition in developing countries: a review. J Physiol Anthropol Appl Human Sci. 2002;21:1–9.PubMedCrossRef
9.
Waitzberg DL, Torrinhas RS, Jacintho TM. New parenteral lipid emulsions for clinical use. Jpen. 2006;30:351–67.CrossRef
10.
Heyland DK, Montalvo M, MacDonald S, et al. Total parenteral nutrition in the surgical patient: a meta-analysis. Can J Surg. 2001;44:102–11.PubMed
11.
Zaloga GP. Improving outcomes with specialized nutrition support. Jpen. 2005;29:S49–52.CrossRef
12.
Cresci G. Targeting the use of specialized nutritional formulas in surgery and critical care. Jpen. 2005;29:S92–95.CrossRef
13.
Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61:284–9.PubMedCrossRef
14.
Falciglia M, Freyberg RW, Almenoff PL, et al. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37:3001–9.PubMedCrossRef
15.
Kosiborod M, Inzucchi SE, Spertus JA, et al. Elevated admission glucose and mortality in elderly patients hospitalized with heart failure. Circulation. 2009;119:1899–907.PubMedCrossRef
16.
Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471–8.PubMedCrossRef
17.
Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978–82.PubMedCrossRef
18.
•• Curll M, Dinardo M, Noschese M, et al. 2010. Menu selection, glycaemic control and satisfaction with standard and patient-controlled consistent carbohydrate meal plans in hospitalised patients with diabetes. Quality & safety in health care 19: 355–359. This is the only randomized controlled trial comparing diabetes-related outcomes between diabetic patients receiving different meal plans in the hospital.
19.
Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Eng J Med. 2006;355:1903–11.CrossRef
20.
American Diabetes Association. Standards of medical care in diabetes--2011. Diabetes care 34 Suppl 1: S11-61.
21.
Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553–91.PubMedCrossRef
22.
Schafer RG, Bohannon B, Franz MJ, et al. Diabetes nutrition recommendations for health care institutions. Diabetes Care. 2004;27 Suppl 1:S55–57.PubMed
23.
Swift CS, Boucher JL. Nutrition therapy for the hospitalized patient with diabetes. Endocr Pract. 2006;12 Suppl 3:61–7.PubMed
24.
McMahon MM, Rizza RA. Nutrition support in hospitalized patients with diabetes mellitus. Mayo Clin Proc. 1996;71:587–94.PubMedCrossRef
25.
Bantle JP, Wylie-Rosett J, Albright AL, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31 Suppl 1:S61–78.PubMed
26.
McClave SA, Martindale RG, Vanek VW, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). Jpen. 2009;33:277–316.CrossRef
27.
Warren J, Bhalla V, Cresci G. Postoperative diet advancement: surgical dogma vs evidence-based medicine. Nutr Clin Pract. 2011;26:115–25.PubMedCrossRef
28.
Anderson AD, Jain PK, MacFie J 2003. Parenteral nutrition in the critically ill. Intensive Care Med 29: 2103; author reply 2104.
29.
Bellantone R, Doglietto G, Bossola M, et al. Preoperative parenteral nutrition of malnourished surgical patients. Acta Chir Scand. 1988;154:249–51.PubMed
30.
Klein S, Kinney J, Jeejeebhoy K, et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr. 1997;66:683–706.PubMed
31.
Marik PE 2006. Death by total parenteral nutrition: part deaux. Crit Care Med 34: 3062; author reply 3062–3063.
32.
Schafer RG, Bohannon B, Franz M, et al. Translation of the diabetes nutrition recommendations for health care institutions. Diabetes Care. 1997;20:96–105.PubMed
33.
Kreymann KG, Berger MM, Deutz NE, et al. 2006. ESPEN Guidelines on Enteral Nutrition: Intensive care. Clinical nutrition (Edinburgh, Scotland) 25: 210–223.
34.
Via MA, Mechanick JI. Inpatient enteral and parenteral [corrected] nutrition for patients with diabetes. Curr Diab Rep. 2010;11:99–105.CrossRef
35.
Craig LD, Nicholson S, SilVerstone FA, et al. Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: results of a pilot trial. Nutrition (Burbank, Los Angeles County. Calif. 1998;14:529–34.
36.
Leon-Sanz M, Garcia-Luna PP, Sanz-Paris A, et al. Glycemic and lipid control in hospitalized type 2 diabetic patients: evaluation of 2 enteral nutrition formulas (low carbohydrate-high monounsaturated fat vs high carbohydrate). Jpen. 2005;29:21–9.CrossRef
37.
Elia M, Ceriello A, Laube H, et al. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care. 2005;28:2267–79.PubMedCrossRef
38.
• Alish CJ, Garvey WT, Maki KC, et al. 2010. A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes. Diabetes technology & therapeutics 12: 419–425. This is a randomized, double-blind, crossover study comparing the effects of continuous 5-day administration of several enteral formulas on carbohydrate metabolism in ambulatory subjects with type 2 diabetes mellitus.
39.
• Ceriello A, Lansink M, Rouws CH, et al. 2009. Administration of a new diabetes-specific enteral formula results in an improved 24h glucose profile in type 2 diabetic patients. Diabetes research and clinical practice 84: 259–266. This is a randomized, double-blind, crossover trial studying glycemic outcomes in ambulatory patients with type 2 diabetes mellitus receiving bolus enteral formulas for 24 hours.
40.
Pohl M, Mayr P, Mertl-Roetzer M, et al. Glycaemic control in type II diabetic tube-fed patients with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids: a randomised controlled trial. Eur J Clin Nutr. 2005;59:1221–32.PubMedCrossRef
41.
Mentec H, Dupont H, Bocchetti M, et al. Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications. Crit Care Med. 2001;29:1955–61.PubMedCrossRef
42.
Heyland DK, Cook DJ, Schoenfeld PS, et al. The effect of acidified enteral feeds on gastric colonization in critically ill patients: results of a multicenter randomized trial. Canadian Critical Care Trials Group. Crit Care Med. 1999;27:2399–406.PubMedCrossRef
43.
•• Korytkowski MT, Salata RJ, Koerbel GL, et al. 2009. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes care 32: 594–596. In this randomized controlled trial authors tested different insulin administration strategies to control hyperglycemia in hospitalized diabetic patients receiving enteral nutrition.
44.
Umpierrez GE. Basal versus sliding-scale regular insulin in hospitalized patients with hyperglycemia during enteral nutrition therapy. Diabetes Care. 2009;32:751–3.PubMedCrossRef
45.
Detsky AS, Baker JP, O'Rourke K, et al. Perioperative parenteral nutrition: a meta-analysis. Ann Intern Med. 1987;107:195–203.PubMed
46.
Muller JM, Brenner U, Dienst C, et al. Preoperative parenteral feeding in patients with gastrointestinal carcinoma. Lancet. 1982;1:68–71.PubMedCrossRef
47.
48.
Bellantone R, Doglietto GB, Bossola M, et al. Preoperative parenteral nutrition in the high risk surgical patient. Jpen. 1988;12:195–7.CrossRef
49.
Klein S, Kinney J, Jeejeebhoy K, et al. 1997. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Clinical nutrition (Edinburgh, Scotland) 16: 193–218.
50.
Cheung NW, Napier B, Zaccaria C, et al. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care. 2005;28:2367–71.PubMedCrossRef
51.
der Voort PH, Feenstra RA, Bakker AJ, et al. Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients. Clin Endocrinol. 2006;64:141–5.CrossRef
52.
Lin LY, Lin HC, Lee PC, et al. Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. Am J Med Sci. 2007;333:261–5.PubMedCrossRef
53.
Pasquel FJ, Spiegelman R, McCauley M, et al. Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care. 2010;33:739–41.PubMedCrossRef
54.
Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29:765–70.PubMedCrossRef
55.
Singer P, Berger MM, Van den Berghe G, et al. 2009. ESPEN Guidelines on Parenteral Nutrition: intensive care. Clinical nutrition (Edinburgh, Scotland) 28: 387–400.
56.
Ziegler TR 2011. Nutrition Support in Critical Illness - Bridging the Evidence Gap. The New England journal of medicine 2011; 365: 562–564.
57.
•• Casaer MP, Mesotten D, Hermans G, et al. 2011. Early versus Late Parenteral Nutrition in Critically Ill Adults. The New England journal of medicine 2011; 365: 506–517. The results of this trial set new standards of nutrition initiation in hospitalized patients requiring PN
58.
Buenestado A, Cortijo J, Sanz MJ, et al. Olive oil-based lipid emulsion's neutral effects on neutrophil functions and leukocyte-endothelial cell interactions. Jpen. 2006;30:286–96.CrossRef
59.
McCowen KC, Friel C, Sternberg J, et al. Hypocaloric total parenteral nutrition: effectiveness in prevention of hyperglycemia and infectious complications–a randomized clinical trial. Crit Care Med. 2000;28:3606–11.PubMedCrossRef
60.
Siqueira J, Smiley D, Newton C, et al. 2011. Substitution of Standard Soybean Oil with Olive Oil-Based Lipid Emulsion in Parenteral Nutrition: Comparison of Vascular, Metabolic and Inflammatory Effects. The Journal of clinical endocrinology and metabolism 2011; 96: 3207–3216.
61.
62.
Yaqoob P. Monounsaturated fatty acids in parenteral nutrition; evaluation of risks and benefits. Br J Nutr. 2005;94:867–8.PubMedCrossRef
63.
Sala-Vila A, Barbosa VM, Calder PC. Olive oil in parenteral nutrition. Curr Opin Clin Nutr Metab Care. 2007;10:165–74.PubMedCrossRef
64.
Nordenstrom J, Jarstrand C, Wiernik A. Decreased chemotactic and random migration of leukocytes during Intralipid infusion. Am J Clin Nutr. 1979;32:2416–22.PubMed
65.
Waitzberg DL, Saito H, Plank LD, et al. Postsurgical infections are reduced with specialized nutrition support. World J Surg. 2006;30:1592–604.PubMedCrossRef
66.
67.
Gosmanov AR, Smiley DD, Robalino G, et al. Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects. Am J Physiol. 2010;299:E953–958.
68.
Umpierrez GE, Smiley D, Robalino G, et al. Intravenous intralipid-induced blood pressure elevation and endothelial dysfunction in obese African-Americans with type 2 diabetes. J Clin Endocrinol Metab. 2009;94:609–14.PubMedCrossRef
69.
Garcia-de-Lorenzo A, Denia R, Atlan P, et al. Parenteral nutrition providing a restricted amount of linoleic acid in severely burned patients: a randomised double-blind study of an olive oil-based lipid emulsion v. medium/long-chain triacylglycerols. Br J Nutr. 2005;94:221–30.PubMedCrossRef
Metadata
Title
Medical Nutrition Therapy in Hospitalized Patients with Diabetes
Authors
Aidar R. Gosmanov
Guillermo E. Umpierrez
Publication date
01-02-2012
Publisher
Current Science Inc.
Published in
Current Diabetes Reports / Issue 1/2012
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-011-0236-5

Other articles of this Issue 1/2012

Current Diabetes Reports 1/2012 Go to the issue

Diabetes and Pregnancy (CJ Homko, Section Editor)

The Placenta and Gestational Diabetes Mellitus

Diabetes and Pregnancy (CJ Homko, Section Editor)

Gestational Diabetes: Implications for Cardiovascular Health

Pediatric Type 2 Diabetes (M Freemark, Section Editor)

Pathogenesis and Prevention of Type 2 Diabetes: Parental Determinants, Breastfeeding, and Early Childhood Nutrition

Hospital Management of Diabetes (M Korytkowski, Section Editor)

Management of Hyperglycemia During the Perioperative Period

Pediatric Type 2 Diabetes (M Freemark, Section Editor)

Type 2 Diabetes in Childhood: Clinical Characteristics and Role of β-Cell Autoimmunity

Pediatric Type 2 Diabetes (M Freemark, Section Editor)

Determining Genetic Risk Factors for Pediatric Type 2 Diabetes
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits